Clover Health is trading at $4.62 (up 11.6%) after reporting a sharp acceleration in growth and a swing to profitability in its second-quarter results.
- The company posted Q2 revenue of $743.2 million, up 56% year-over-year, which beat analyst expectations.
- Clover Health delivered GAAP net income of $28.0 million ($0.05 per share) and raised its full-year 2026 guidance for revenue, profitability, and membership.